These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis. Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110 [TBL] [Abstract][Full Text] [Related]
28. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register. Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630 [TBL] [Abstract][Full Text] [Related]
29. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry. Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M; Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524 [TBL] [Abstract][Full Text] [Related]
30. Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication. Boersma LV; Barr CS; Burke MC; Leon AR; Theuns DA; Herre JM; Weiss R; Kremers MS; Neuzil P; Husby MP; Carter N; Stivland TM; Gold MR; Heart Rhythm; 2017 Mar; 14(3):367-375. PubMed ID: 27890798 [TBL] [Abstract][Full Text] [Related]
31. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death. Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108 [TBL] [Abstract][Full Text] [Related]
39. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life. Merchant FM; Jones P; Wehrenberg S; Lloyd MS; Saxon LA J Am Heart Assoc; 2014 Nov; 3(6):e001289. PubMed ID: 25385346 [TBL] [Abstract][Full Text] [Related]
40. Venous thromboembolism in patients with implantable cardioverter-defibrillators. Pedersen SB; Hjortshøj SP; Bøtker HE; Farkas DK; Schmidt M; Sørensen HT; Nielsen JC Europace; 2017 Jun; 19(6):991-1001. PubMed ID: 27256414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]